CHICAGO – Results from five late-breaking studies released today at the American Society of Clinical Oncology’s (ASCO) 51st Annual Meeting provide important new treatment options for patients with common and rare cancers. They include new or refined therapies for melanoma, prostate and breast cancers, which are together diagnosed in more than 500,000 Americans annually.
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) announced today the appointment of David Kerr, MD, DSc, as founding Editor-in-Chief of the Society’s new Journal of Global Oncology (JGO). Prof. Kerr will set the editorial scope and vision for JGO, an online-only, open-access journal that will focus on cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources.
CHICAGO – The American Society of Clinical Oncology’s (ASCO) wholly owned non-profit subsidiary, CancerLinQ LLC, will provide the first demonstration of its groundbreaking health information technology (HIT) platform at ASCO’s 51st Annual Meeting.
ALEXANDRIA, VA – The American Society of Clinical Oncology (ASCO) today announced that its wholly owned subsidiary, CancerLinQ LLC, will use the SAP HANA® platform in the development of ASCO’s CancerLinQ™. CancerLinQ is a groundbreaking health information technology (HIT) platform that will harness Big Data to deliver high-quality care to patients with cancer. It is one of the only major cancer data initiatives being developed and led by physicians with the primary purpose of improving patient care.
ASCO issued a new template for healthcare professionals to use when providing a survivorship care plan to patients who have completed curative cancer therapy.
Robert S. Miller, MD, FACP, FASCO, Assistant Professor of Oncology and Oncology Medical Information Officer at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, has been named Medical Director of the Institute for Quality (iQ) of the American Society of Clinical Oncology (ASCO).
The American Society of Clinical Oncology (ASCO) today announced the “Top 5 Advances in 50 Years of Modern Oncology,” based on results of worldwide voting on CancerProgress.Net – ASCO’s interactive website documenting the history of progress against cancer.
The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) has received a major commitment of support for the development of CancerLinQ™ from Cancer Treatment Centers of America, Inc. (CTCA), a national network of five cancer hospitals.
ALEXANDRIA, VA -- The American Society of Clinical Oncology (ASCO) has issued new recommendations for the use of sentinel lymph node biopsy in patients with early stage breast cancer. The guideline, "Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update," was published today in the Journal of Clinical Oncology.
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today highlighted seven studies in a presscast from among more than 4,500 abstracts publicly posted online at abstract.asco.org in advance of ASCO’s 49th Annual Meeting.
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) and the Lance Armstrong Foundation today announced the launch of a new video series for young adults with cancer that is featured on ASCO’s patient information website and on the Foundation’s YouTube site. The series, “Moving Forward: Perspectives from Survivors and Doctors,” addresses critical issues that young adults with cancer may face and helps them better understand and cope with challenges related to their diagnosis.